Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Löwer

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 17, 2010
[Pandemic influenza vaccines. How should they be designed?]J Löwer
Journal of Medical Virology|May 1, 1990
Risk of tumor induction in vivo by residual cellular DNA: quantitative considerationsJ Löwer
Arzneimittel-Forschung|March 1, 1988
[Gene technology in the diagnosis of viruses and vaccine development]J Löwer
Vox Sanguinis|December 16, 1998
GB virus C/hepatitis G virus and intravenous immunoglobulinsC Nübling, A Gröner, J Löwer
Vaccine|December 12, 2001
Cold-attenuated live influenza vaccines, a risk-benefit assessmentM Pfleiderer, J Löwer, R Kurth
AIDS (London, England)|April 1, 1991
High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccinesF Stieneker, J Kreuter, J Löwer
Biologicals : Journal of the International Association of Biological Standardization|February 25, 2000
Safety issues for plasma derivatives and benefit from NAT testingH Willkommen, I Schmidt, J Löwer
Proceedings of the National Academy of Sciences of the United States of America|May 28, 1996
The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequencesR Löwer, J Löwer, R Kurth
Journal of Virology|October 9, 1999
cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-KC Magin, R Löwer, J Löwer
Journal of Virology|January 9, 1999
Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1M Knössl, R Löwer, J Löwer
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 17, 2010
[Pandemic influenza vaccines. How should they be designed?]J Löwer
Journal of Medical Virology|May 1, 1990
Risk of tumor induction in vivo by residual cellular DNA: quantitative considerationsJ Löwer
Arzneimittel-Forschung|March 1, 1988
[Gene technology in the diagnosis of viruses and vaccine development]J Löwer
Vox Sanguinis|December 16, 1998
GB virus C/hepatitis G virus and intravenous immunoglobulinsC Nübling, A Gröner, J Löwer
Vaccine|December 12, 2001
Cold-attenuated live influenza vaccines, a risk-benefit assessmentM Pfleiderer, J Löwer, R Kurth
AIDS (London, England)|April 1, 1991
High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccinesF Stieneker, J Kreuter, J Löwer
Biologicals : Journal of the International Association of Biological Standardization|February 25, 2000
Safety issues for plasma derivatives and benefit from NAT testingH Willkommen, I Schmidt, J Löwer
Proceedings of the National Academy of Sciences of the United States of America|May 28, 1996
The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequencesR Löwer, J Löwer, R Kurth
Journal of Virology|October 9, 1999
cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-KC Magin, R Löwer, J Löwer
Journal of Virology|January 9, 1999
Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1M Knössl, R Löwer, J Löwer
Pageof 5